Is EL a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Margin recovery from the Profit Recovery and Growth Plan, with revenue (ttm) at ~$14.8 billion. The bear case rests on reported earnings remain negative on a trailing twelve month basis, with a net loss of ~$248 million and EPS of ~-$0.69, so the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Analysts covering it are spread from $70.00 to $125.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Reported earnings remain negative on a trailing twelve month basis, with a net loss of ~$248 million and EPS of ~-$0.69, so the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $70.00, -20.8% from the $88.35 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Margin recovery from the Profit Recovery and Growth Plan. Adjusted operating margin reached 15.0% in the March 2026 quarter versus 11.4% a year earlier, and adjusted gross margin expanded 140 basis points to 76.4%. The most optimistic analyst target on EL is $125.00, +41.5% from the $88.35 price. That figure is only reachable if this thesis works close to its best case.

Reported earnings remain negative on a trailing twelve month basis, with a net loss of ~$248 million and EPS of ~-$0.69, so the valuation rests on adjusted and forward numbers rather than delivered GAAP profit. Leverage is meaningful at ~$9.3 billion of total debt against ~$3.1 billion of cash, roughly ~$6.2 billion net, while the Class A buyback has been suspended since December 2022 and the dividend was cut to $0.35 per quarter. A securities class action in the Southern District of New York (In re The Estee Lauder Companies, Inc. Securities Litigation, No. 1:23-cv-10669, S.D.N.Y.) over travel retail and daigou disclosures survived a motion to dismiss in March 2025 and reached an agreement in principle to settle for $210 million on April 2, 2026, with preliminary approval granted May 13, 2026 and a final approval hearing set for August 20, 2026; several shareholder derivative suits over the same conduct remain outstanding in New York and Delaware, and cosmetic talcum powder asbestos claims are being resolved under settlement frameworks running through 2029. Tariffs are expected to reduce fiscal 2026 profitability by ~$100 million, and because tariff costs are capitalised in inventory for roughly six months, later rate reductions do not help the current year. Middle East disruption, which touched ~2% of fiscal 2025 net sales, was flagged as a larger drag on the June 2026 quarter than on the March quarter. The most pessimistic published target is $70.00, -20.8% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

The Estee Lauder Companies is the prestige beauty group behind La Mer, Clinique, M.A.C and Jo Malone London, with roughly $14.8 billion in trailing net sales.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Margin recovery from the Profit Recovery and Growth Plan) stalling in the reported numbers rather than in the narrative, the risk above (reported earnings remain negative on a trailing twelve month basis, with a net loss of ~$248 million and EPS of ~-$0.69, so the valuation rests on adjusted and forward numbers rather than delivered GAAP profit) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Prestige beauty in four categories: skin care, makeup, fragrance and hair care. Skin care is the largest at ~$5.5 billion of net sales in the first nine months of fiscal 2026, ahead of makeup at ~$3.3 billion and fragrance at ~$2.2 billion. Roughly two dozen brands sit under the group, including La Mer, Clinique, M.A.C, Jo Malone London, Tom Ford Beauty and The Ordinary.

Yes. Class A shares trade on the NYSE under EL and carry one vote each. Class B shares, held largely by members of the Lauder family, carry ten votes each and are not publicly traded. With ~114.5 million Class B shares outstanding at March 31, 2026 against ~247 million Class A shares outstanding, the Class B block alone represents roughly ~82% of total voting power, so public shareholders have economic exposure with limited voting influence.

Trailing twelve month net income is ~-$248 million. Fiscal 2025 carried ~$861 million of goodwill and intangible impairments plus ~$159 million of talc settlement charges, and fiscal 2026 has absorbed ~$520 million of restructuring charges in nine months plus an $84 million net securities settlement charge. Adjusted operating income was ~$557 million in the March 2026 quarter, which is the number management points to.